Venous Stenosis
11
3
6
2
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 25/100
0.0%
0 terminated out of 11 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
100%
2 of 2 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (11)
The GORE® VIABAHN® FORTEGRA Venous Stent Post-Approval Study
The GORE® VIABAHN® FORTEGRA Venous Stent IVC Study
The GORE® VIABAHN® FORTEGRA Venous Stent Iliofemoral Study
The Solaris DE Endoprosthesis for the Treatment of AV Access Stenosis or Occlusion
WRAP North America
Merit WRAPSODY™ Endoprosthesis for Treatment of Stenosis or Occlusion (WRAP)
The Merit WRAPSODY AV Access Efficacy Study (WAVE)
Sirolimus Use in Angioplasty for Vascular Access Extension
The Merit WRAPSODY™ Endovascular Stent Graft
The Merit WRAPSODY Central Feasibility Study
Duration and Adverse Events of Non-cuffed Catheter in Patients With Hemodialysis